Catalyst
Slingshot members are tracking this event:
TRACON (TCON) Pharmaceuticals Announces Successful Meetings with FDA and EMA for TRC105 (carotuximab) in Angiosarcoma
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| TCON | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 03, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Tracon, Trc105, Carotuximab, Angiosarcoma
